Suppression of the NF-κB co-factor, Bcl3, delays the metastatic progression of breast cancer

Documenti analoghi

• Suppression of the NF-κB cofactor Bcl3 inhibits mammary epithelial cell apoptosis and, in breast tumours, correlates with poor prognosis
  di: Wakefield, A, et al.
  Pubblicazione: (2008)
• NF-κB and Bcl-3 Activation Are Prognostic in Metastatic Colorectal Cancer
  di: Puvvada, Soham D., et al.
  Pubblicazione: (2010)
• Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells
  di: Bhaumik, D, et al.
  Pubblicazione: (2008)
• NF-κB Signaling Is Regulated by Fucosylation in Metastatic Breast Cancer Cells
  di: Doud, Emma H., et al.
  Pubblicazione: (2020)
• The membrane protein of SARS‐CoV suppresses NF‐κB activation
  di: Fang, Xiaonan, et al.
  Pubblicazione: (2007)